Latest News

Spyre Therapeutics develops preclinical monoclonal antibody therapies targeting inflammatory bowel disease and related conditions.
Via The Motley Fool · February 23, 2026
These companies just turned in fourth-quarter earnings reports that should have investors salivating at their upside in 2026 and beyond.
Via The Motley Fool · February 23, 2026
While Fair Isaac has considerably trailed the S&P 500 over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Via Barchart.com · February 23, 2026
Via Talk Markets · February 23, 2026
GeneDx Holdings Corp (NASDAQ:WGS) Reports Mixed Q4 2025 Results, Stock Falls Despite Strong 2026 Outlookchartmill.com
Via Chartmill · February 23, 2026
Axsome Therapeutics Inc (NASDAQ:AXSM) Reports Q4 2025 Results, Meeting Revenue Forecasts but Posting Wider Losschartmill.com
Via Chartmill · February 23, 2026
Stepan Co. (NYSE:SCL) Stock Plummets 16% After Q4 Earnings Misschartmill.com
Via Chartmill · February 23, 2026
In a landmark decision for the cardiovascular treatment landscape, the European Commission (EC) officially granted marketing authorization to Cytokinetics, Inc. (Nasdaq: CYTK) on February 17, 2026, for its innovative cardiac drug, MYQORZO (aficamten). The approval clears the way for the treatment of adult patients suffering from symptomatic obstructive hypertrophic cardiomyopathy
Via MarketMinute · February 23, 2026
The financial landscape of 2026 has opened with a dramatic shift in market leadership, as small-cap stocks stage a historic rally that has left large-cap tech giants in the rearview mirror. After years of dominance by a handful of "Magnificent 7" companies, the tide has turned toward the "median stock,
Via MarketMinute · February 23, 2026
A positive surprise this quarter could silence the skeptics.
Via Barchart.com · February 23, 2026
Lincoln Educational Services (NASDAQ:LINC) Surges on Strong Q4 Earnings Beat and Upbeat 2026 Guidancechartmill.com
Via Chartmill · February 23, 2026
What's going on in today's session: S&P500 gap up and gap down stockschartmill.com
Via Chartmill · February 23, 2026
The midstream oil and gas company has scheduled its fourth-quarter earnings on Feb. 23.
Via The Motley Fool · February 23, 2026
The S&P 500 (NYSE:SPY) could plunge to 3,500 by 2028 if the AI revolution succeeds too well, according to a chilling “pre-mortem” scenario released by Ci
Via Benzinga · February 23, 2026
Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby, CoreWeave, Salesforce, Lucid and more.
Via Benzinga · February 23, 2026
Opendoor stock soared on Friday as the iBuyer reports better-than-expected Q4 earnings. Still, there’s reason to avoid buying OPEN shares into the post-release strength.
Via Barchart.com · February 23, 2026
Although Everest Group has lagged the S&P 500 over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Via Barchart.com · February 23, 2026
In a definitive move to solidify its position as a leader in the environmental services sector, Republic Services Inc. (NYSE: RSG) released its full-year 2026 financial guidance on February 17, 2026, outlining a strategic pivot toward high-margin municipal contracts and an aggressive expansion of its waste-to-energy portfolio. The company, which
Via MarketMinute · February 23, 2026
Shares of InMode Ltd (NASDAQ: INMD) are trading lower Monday morning after the Israeli medical technology company said a special independent transaction committee has ended its strategic review without pursuing any deal.
Via Benzinga · February 23, 2026
Gov. Gavin Newsom considering 2028 White House run, influenced by son's text. Rising national profile through opposition to Trump.
Via Benzinga · February 23, 2026
In a tale of two markets, Caesars Entertainment (NASDAQ:CZR) reported a fourth-quarter earnings result that underscored a profound shift in the gaming giant’s financial architecture. While the glitz and glamour of the Las Vegas Strip showed signs of a post-pandemic "normalization"—marked by cooling hotel rates and lower
Via MarketMinute · February 23, 2026
The U.S. Food and Drug Administration has granted premarket approval for Allurion’s Gastric Balloon System with the swallowable Allurion Smart Capsule.
Via Stocktwits · February 23, 2026
These stocks are gapping in today's sessionchartmill.com
Via Chartmill · February 23, 2026
These Canadian growth stocks are backed by fundamentally strong businesses and are witnessing solid demand.
Via The Motley Fool · February 23, 2026

Centessa Pharmaceuticals develops clinical-stage therapies for rare and serious diseases, leveraging a portfolio approach in biopharma.
Via The Motley Fool · February 23, 2026
In a pivotal moment for the consumer health landscape, Kenvue (NYSE: KVUE) has reported a robust set of fourth-quarter results for 2025, signaling a successful turnaround and strategic resilience just months after the announcement of its blockbuster merger. On February 17, 2026, the company revealed that its Q4 net sales
Via MarketMinute · February 23, 2026
Palo Alto Networks (NASDAQ: PANW) has once again redefined the cybersecurity landscape with its fiscal second-quarter 2026 results, proving that the controversial "platformization" strategy launched two years ago is bearing significant fruit. Despite a minor post-earnings dip in share price due to integration costs associated with its massive $25 billion
Via MarketMinute · February 23, 2026
In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third fiscal quarter of 2026. On February 17, 2026, the Dublin-based medical device giant announced total revenue of $9.017 billion,
Via MarketMinute · February 23, 2026
As of February 23, 2026, ONEOK, Inc. (NYSE: OKE) stands as a titan of the North American midstream energy landscape. In the wake of a historic three-year consolidation phase—marked by the transformative acquisition of Magellan Midstream Partners and the subsequent 2024 integrations of EnLink Midstream and Medallion Midstream—ONEOK has evolved from a pure-play natural gas [...]
Via Finterra · February 23, 2026
With yields of up to 6%, these three reliable income generators are still attractive buys as February draws to a close.
Via The Motley Fool · February 23, 2026

Stepan (SCL) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 23, 2026
As of February 23, 2026, the biotechnology landscape has shifted away from the speculative fervor of the early 2020s toward a demand for commercial execution and sustainable revenue. Standing at the center of this transformation is Axsome Therapeutics (Nasdaq: AXSM), a mid-cap CNS (Central Nervous System) specialist that has successfully navigated the "valley of death" [...]
Via Finterra · February 23, 2026
The enterprise software sector, long the crown jewel of Wall Street’s growth portfolio, is currently grappling with a fundamental identity crisis that has wiped out nearly $1 trillion in market value since the start of the year. Investors have rapidly soured on the traditional "Software-as-a-Service" (SaaS) model, fearing that
Via MarketMinute · February 23, 2026
As of February 23, 2026, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself at a critical crossroads that has sent shockwaves through the telehealth and pharmaceutical sectors. Once the darling of the "personalized medicine" movement, the company is currently grappling with extreme stock volatility following a series of aggressive regulatory maneuvers and high-stakes litigation [...]
Via Finterra · February 23, 2026

Nuvalent develops targeted cancer therapies, advancing clinical candidates for patients with limited treatment options in oncology.
Via The Motley Fool · February 23, 2026
Precious metals experienced a dramatic breakout during Monday’s trading session on February 23, 2026, as a "perfect storm" of domestic legal battles and rising military tensions in the Middle East sent investors scurrying for safety. Gold futures surged more than 2%, breaching the psychologically significant $5,100 level, while
Via MarketMinute · February 23, 2026
On this Monday, February 23, 2026, the global leader in pizza delivery finds itself in an enviable but high-stakes position. As Domino’s Pizza, Inc. (NYSE: DPZ) releases its fourth-quarter and full-year 2025 earnings report this morning, the market is closely watching to see if the "Hungry for MORE" strategy—launched by CEO Russell Weiner in late [...]
Via Finterra · February 23, 2026
Tilray Brands is expanding its business at a rapid clip, but there are risks associated with this growth effort.
Via The Motley Fool · February 23, 2026
The U.S. bond market witnessed a significant shift in sentiment this February, as the benchmark 10-year Treasury yield drifted down to approximately 4.09%, marking a notable retreat from the highs seen in late 2025. This downward move reflects a growing consensus among investors that the long-standing battle against
Via MarketMinute · February 23, 2026
As of February 23, 2026, the energy sector’s eyes are fixed on Midland, Texas. Diamondback Energy (NASDAQ: FANG), the undisputed heavyweight champion of Permian Basin independent producers, has just released its fourth-quarter 2025 earnings. In a market defined by fluctuating crude prices and a fierce industry-wide mandate for capital discipline, Diamondback stands as a case [...]
Via Finterra · February 23, 2026
On February 23, 2026, LyondellBasell (NYSE: LYB) stands at a critical crossroads. Once celebrated as a high-yield dividend powerhouse of the petrochemical sector, the company has spent the early months of 2026 aggressively restructuring its identity. Today’s market developments—including a major recalibration of its 2030 sustainability targets and a significant shift in capital allocation—signal a [...]
Via Finterra · February 23, 2026
Via Benzinga · February 23, 2026
A new note from Citrini Research imagines a 2028 scenario where AI-driven cuts at Salesforce push former $180,000 earners into $45,000 gig work on Uber, triggering broader wage compression and weaker consumer spending.
Via Benzinga · February 23, 2026
As the sun begins to set on the era of Jerome Powell, the landscape of American finance is bracing for a tectonic shift. The nomination of Kevin Warsh to succeed Powell as the Chair of the Federal Reserve (NYSEARCA:SPY) marks a pivotal moment in the history of the central
Via MarketMinute · February 23, 2026
Via MarketBeat · February 23, 2026
Airgain slips despite securing a multi-year, multi-million-dollar 5G design win, ahead of an expected earnings report showing a loss.
Via Benzinga · February 23, 2026
As of February 23, 2026, Caterpillar Inc. (NYSE: CAT) stands at a historic crossroads. Long regarded as the global bellwether for industrial health, the "Yellow Iron" giant is currently the center of intense market speculation following a series of fiscal and judicial developments that suggest a massive capital windfall is imminent. While Caterpillar has spent [...]
Via Finterra · February 23, 2026
A Chinese-born crypto billionaire referenced Web 4.0 adoption for TRON, including the development of AI agents that would operate on blockchain networks.
Via Stocktwits · February 23, 2026
The U.S. retail sector is reeling this Monday, February 23, 2026, as a sweeping new 15% global tariff takes hold, sending shockwaves through the supply chains of the nation’s largest apparel brands. Markets opened to a sea of red for companies heavily reliant on overseas manufacturing, with industry
Via MarketMinute · February 23, 2026
On February 23, 2026, Walmart Inc. (NYSE: WMT) solidified its position as a dominant titan of the modern economy, with its market capitalization officially crossing the historic $1 trillion threshold. This milestone comes during a transformative week for the retail giant, fueled by a landmark U.S. Supreme Court ruling regarding tariff refunds that has sent [...]
Via Finterra · February 23, 2026